E Fischer

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Kimberly J. Van Zee, Tadahiko Kohno, E Fischer et al. · Proceedings of the National Academy of Sciences · 1992 · 851 citations · Full text

Immunology, Immune Regulation, Pathology +20

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.

E Fischer, Michael A. Marano, Kimberly J. Van Zee et al. · Journal of Clinical Investigation · 1992 · 334 citations · Full text

Inflammation, Il-1 Receptor Antagonist, Cytokine +14

IL-8 in septic shock, endotoxemia, and after IL-1 administration

Kimberly J. Van Zee, Laura DeForge, E Fischer et al. · The Journal of Immunology · 1991 · 308 citations

Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man

Amelia E. Barber, S M Coyle, Michael A. Marano et al. · The Journal of Immunology · 1993 · 289 citations · Full text

Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease

E Fischer, KJ Van Zee, MA Marano et al. · Blood · 1992 · 211 citations · Full text